Development of a system for controlled release of benzo(a)pyrene, 7,12-dimethylbenz(a)anthracene, and phorbol ester for tumor induction in heterotopic tracheal grafts.
D015127:9,10-Dimethyl-1,2-benzanthracene / Q000008:administration & dosage*; D000818:Animals; D001516:Bees; D001551:Benz(a)Anthracenes / Q000008:administration & dosage*; D001580:Benzopyrenes / Q000008:administration & dosage*; D002244:Carbon; D003692:Delayed-Action Preparations; D009374:Neoplasms, Experimental / Q000139:chemically induced; D010704:Phorbols / Q000008:administration & dosage*; D051381:Rats; D011916:Rats, Inbred F344; D012995:Solubility; D013755:Tetradecanoylphorbol Acetate / Q000008:administration & dosage*; D014132:Trachea / Q000637:transplantation; D014134:Tracheal Neoplasms / Q000139:chemically induced* / Q000473:pathology; D014185:Transplantation, Isogeneic; D014885:Waxes
D001551:Benz(a)Anthracenes; D001580:Benzopyrenes; D003692:Delayed-Action Preparations; D010704:Phorbols; D014885:Waxes; D015127:9,10-Dimethyl-1,2-benzanthracene; D002244:Carbon; D013755:Tetradecanoylphorbol Acetate